May 5th, 2008 Stock Pick: NeuroMetrix, Inc. (NURO)

Stock Price: $2.42

NeuroMetrix, Inc. is a science based medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the diagnosis and treatment of diseases of the nervous system and neurovascular disorders, and that provide regional anesthesia and pain control.

On April 28th, NURO received clearance for their ADVANCE(TM) system for the performance of nerve conduction studies. NURO is now allowed to market ADVANCE(TM) in the US market. NURO surged after receiving clearance, moving from the $1.65 level to $3.24.

NURO has since settled in at a bottom in its chart and looks ready to start another leg higher. Any catalyst could set it higher again.

The company has strong fundamentals with $29.76 million in cash and short term investments on the balance sheet with very little long term debt. NURO is trading at a market cap of only around $33.13 million.

DISCLAIMER & RISK DISCLOSURE: and StockShark, LLC and our affiliates ("our companies") are not registered investment advisers or broker/dealers. Our companies make no commitment that the purchase of securities of companies profiled or otherwise mentioned in our websites are suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the possible lack of liquidity for their securities, investing in such securities is highly speculative and carries a high degree of risk. Never invest based solely on information from this Web site or our email alerts. Our Newsletter is our free alert email membership. We profile selected companies on our site. These companies compensate StockShark, LLC for profile coverage. This compensation can be found in the disclosure on the bottom of the page of profiles. This Disclaimer & Risk Disclosure is also at the bottom of profiles. Specific questions on membership or profiles can be obtained by writing the at: